重组Anti-TRIM21/SS-A抗体[EPR20290]
Anti-TRIM21/SS-A antibody [EPR20290]
- BOND RX™ Validated
- RabMAb
- Recombinant
- KO Validated
- 了解详情
Be the first to review this product! Submit a review
|
(19 Publications)
Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) is a rabbit monoclonal antibody detecting TRIM21/SS-A in Western Blot, IHC-P. Suitable for Human, Mouse, Rat.
- KO validated for confirmed specificity
- Biophysical QC for unrivalled batch-batch consistency
查看别名
RNF81, RO52, SSA1, TRIM21, E3 ubiquitin-protein ligase TRIM21, 52 kDa Ro protein, 52 kDa ribonucleoprotein autoantigen Ro/SS-A, RING finger protein 81, Ro(SS-A), Sjoegren syndrome type A antigen, Tripartite motif-containing protein 21, SS-A
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
Immunohistochemistry analysis of paraffin-embedded human tonsil tissue sections labelling TRIM21/SS-A with ab207728 at 1/100 dilution. The section was incubated with ab207728 for 10 mins at room temperature. Ready to use Leica DS9800 (Bond™ Polymer Refine Detection) was used as the secondary antibody. Sections were counterstained with Hematoxylin. Antigen retrieval was heat mediated with Tris-EDTA buffer (pH 9.0, epitope retrieval solution2) for 20 minutes.
Positive staining on human tonsil. The immunostaining was performed on a Leica Biosystems BOND® RX instrument.
- IHC-P
Supplier Data
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
Immunohistochemical analysis of paraffin-embedded A : Wild-type A549 (Human lung carcinoma epithelial cell) cell pellet, B : TRIM21 knockout A549 (ab267080) cell pellet labelling TRIM21/SS-A with ab207728 at 1/500 dilution (1.212 μg/ml) followed by LeicaDS9800 (Bond™ Polymer Refine Detection) secondary antibody at a ready to use concentration. Positive staining on (A) wild-type A549 cell pellet, no staining on (B) TRIM21 knockout A549 (ab267080) cell pellet. The section was incubated with ab207728 for 10 mins at room temperature. The immunostaining was performed on a Leica Biosystems BOND® RX instrument. Counterstained with Hematoxylin.
Heat mediated antigen retrieval was performed with Tris-EDTA buffer (pH 9.0, Epitope Retrieval Solution2) for 20 mins.
- WB
Supplier Data
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) at 1/1000 dilution
Lane 1:
HEK-293T (human epithelial cell line from embryonic kidney transformed with large T antigen), whole cell lysate at 20 µg
Lane 2:
MOLT-4 (human lymphoblastic leukemia cell line), whole cell lysate at 20 µg
Lane 3:
Human fetal spleen lysate at 20 µg
Lane 4:
Human fetal kidney lysate at 20 µg
Lane 5:
Human thymus lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 54 kDa
Observed band size: 50 kDa
true
Exposure time: 3min
- WB
Lab
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
Lanes 1 - 4 : Merged signal (red and green). Green - ab207728 observed at 50 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab207728 was shown to specifically react with in wild-type HAP1 cells as signal was lost in TRIM21 knockout cells. Wild-type and TRIM21 knockout samples were subjected to SDS-PAGE. The membrane was blocked with 3% NF Milk. ab207728 and ab8245 (Mouse anti-GAPDH loading control) were incubated overnight at 4°C at 1/1000 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) at 1/1000 dilution
Lane 1:
Wild-type HAP1 whole cell lysate at 20 µg
Lane 2:
TRIM21 knockout HAP1 whole cell lysate at 20 µg
Lane 3:
HeLa whole cell lysate at 20 µg
Lane 4:
MOLT-4 whole cell lysate at 20 µg
Predicted band size: 54 kDa
false
- WB
Lab
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
Lanes 1-4 : Merged signal (red and green). Green - ab207728 observed at 50 kDa. Red - loading control ab8245 observed at 36 kDa.
ab207728 Anti-TRIM21/SS-A antibody [EPR20290] was shown to specifically react with TRIM21/SS-A in wild-type A549 cells. Loss of signal was observed when knockout cell line ab267024 (knockout cell lysate ab257766) was used. Wild-type and TRIM21/SS-A knockout samples were subjected to SDS-PAGE. ab207728 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 1000 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) at 1/1000 dilution
Lane 1:
Wild-type A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
TRIM21 knockout A549 (Human lung carcinoma cell line) whole cell lysate at 20 µg
Lane 2:
Western blot - Human TRIM21 (SS-A) knockout A549 cell line (<a href='/products/cell-lines/human-trim21-ss-a-knockout-a549-cell-line-ab267024'>ab267024</a>)
Lane 3:
HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) whole cell lysate at 20 µg
Lane 4:
MOLT-4 (Human lymphoblastic leukemia cell line) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 54 kDa
Observed band size: 50 kDa
false
- WB
Lab
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
Lanes 1-4 : Merged signal (red and green). Green - ab207728 observed at 50 kDa. Red - loading control ab8245 observed at 36 kDa.
ab207728 Anti-TRIM21/SS-A antibody [EPR20290] was shown to specifically react with TRIM21/SS-A in wild-type A549 cells. Loss of signal was observed when knockout cell line ab267025 (knockout cell lysate ab257767) was used. Wild-type and TRIM21/SS-A knockout samples were subjected to SDS-PAGE. ab207728 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) were incubated overnight at 4°C at 1 in 500 dilution and 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) at 1/500 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
TRIM21 knockout A549 cell lysate at 20 µg
Lane 2:
Western blot - Human TRIM21 (SS-A) knockout A549 cell line (<a href='/products/cell-lines/human-trim21-ss-a-knockout-a549-cell-line-ab267025'>ab267025</a>)
Lane 3:
HeLa cell lysate at 20 µg
Lane 4:
MOLT-4 cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-irdye-800cw-preadsorbed-ab216773'>ab216773</a>) at 1/10000 dilution
Predicted band size: 54 kDa
Observed band size: 50 kDa
false
- WB
Supplier Data
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
ab207728 was shown to react with TRIM21 in wild-type A549 cells in Western blot with loss of signal observed in TRIM21 knockout cell line ab267025. Wild-type A549 and TRIM21 knockout cell lysates were subjected to SDS-PAGE. Membranes were blocked in 5% milk in TBST for 1 hr before incubation with ab207728 overnight at 4 °C at a 1/1000 dilution. Blots were incubated with secondary antibodies at 0.2 µg/mL before imaging.
This data was provided by YCharOS Inc., an open science company with the mission of characterizing commercially available antibody reagents for all human proteins. Abcam and YCharOS are working together to help address the reproducibility crisis by enabling the life science community to better evaluate commercially available antibodies.
All lanes:
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) at 1/1000 dilution
Lane 1:
Wild-type A549 lysate at 30 µg
Lane 2:
TRIM21 knock-out A549 lysate at 30 µg
false
- WB
Supplier Data
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
Blocking/Dilution buffer : 5% NFDM/TBST.
The level of TRIM21 expression can be elevated by IFN alpha treatment (PMID : 18071879).
All lanes:
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) at 1/1000 dilution
Lane 1:
Untreated HeLa (human epithelial cell line from cervix adenocarcinoma), whole cell lysate at 10 µg
Lane 2:
HeLa (human epithelial cell line from cervix adenocarcinoma) treated with 10 ng/ml human interferon-α (<a href='/products/proteins-peptides/recombinant-human-interferon-alpha-1-protein-active-ab48750'>ab48750</a>) for 16 hours at 10 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 54 kDa
Observed band size: 50 kDa
true
Exposure time: 3min
- WB
Supplier Data
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (AB207728)
Exposure times : Lane 1-2 : 30 seconds; Lane 3 : 3 minutes.
Blocking/Dilution buffer : 5% NFDM/TBST.
All lanes:
Western blot - Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) at 1/1000 dilution
Lane 1:
Rat spleen lysate at 20 µg
Lane 2:
Rat thymus lysate at 20 µg
Lane 3:
Mouse thymus lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/100000 dilution
Predicted band size: 54 kDa
Observed band size: 50 kDa
true
不同偶联物与剂型 (1)
-
Anti-TRIM21/SS-A antibody [EPR20290] - BSA and Azide free
反应性数据
产品详情
What is this antibody validated in?
Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) is a rabbit recombinant monoclonal antibody and is validated for use in Western Blot (WB), Immunohistochemistry (IHC-P) in Human, Mouse, Rat samples.
What is the molecular weight of TRIM21/SS-A?
Anti-TRIM21/SS-A [EPR20290] (ab207728) specifically detects a band for TRIM21/SS-A (UniProt: P19474) at a molecular weight of 54kDa.
Trusted by the scientific community
Anti-TRIM21/SS-A [EPR20290] (ab207728) was first used in a scientific publication in 2017 and has been cited over 10 times in peer-reviewed journals.
Trial sizes available!
Test your antibody or perform pre-screening before committing to a larger quantity. Sold in 10µl. Discover our selection of trial-size antibodies.
Specificity confirmed
The specificity of Anti-TRIM21/SS-A antibody [EPR20290] (ab207728) has been confirmed by Western blot testing in TRIM21 Knockout HAP1 cell line, ab267024.
Other related products
We have a range of other formats of antibody clone [EPR20290] also available for your convenience: ab207728, Carrier free - ab232549
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存时间
推荐的短期储存条件
推荐的长期储存条件
分装信息
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TRIM21 contributes significantly to the regulation of immune responses and participates in innate and adaptive immunity. It forms part of a complex with other proteins to facilitate the degradation of viral particles through the ubiquitin-proteasome system a process known as antibody-dependent intracellular neutralization. As an important player in the immune defense TRIM21 oversees the timely removal of pathogens and prevents potential overactivation of immune responses that might harm the host.
Pathways
TRIM21 operates within the interferon signaling and NF-κB pathways two important areas of immune response modulation. TRIM21 interacts with molecules like transcription factors that influence the expression of interferon-responsive genes which are critical for pathogen defense. Its role in these pathways highlights its interactions with various immune-regulatory proteins helping to maintain immune system balance and effectiveness during infections.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (19)
Recent publications for all applications. Explore the full list and refine your search
Experimental & molecular medicine 57:1555-1566 PubMed40610751
2025
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 16:3516 PubMed40229254
2025
Applications
Unspecified application
Species
Unspecified reactive species
Autophagy 21:178-190 PubMed39172027
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of nanobiotechnology 22:464 PubMed39095755
2024
Applications
Unspecified application
Species
Unspecified reactive species
Life science alliance 7: PubMed38977311
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of hematology & oncology 17:45 PubMed38886748
2024
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 27:213 PubMed38590560
2024
Applications
Unspecified application
Species
Unspecified reactive species
British journal of cancer 130:526-541 PubMed38182686
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 14:825 PubMed38092733
2023
Applications
Unspecified application
Species
Unspecified reactive species
NPJ breast cancer 9:85 PubMed37864041
2023
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com